Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Familial Cancer

• Publication date

  2022-07-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10689-022-00304-1PMID 35802266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

  2021cited by this paper
• Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients

  2020cited by this paper
• Trends and Projections in Breast Cancer Mortality among four Asian countries (1990–2017): Evidence from five Stochastic Mortality Models

  2020cited by this paper
• Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma

  2020cited by this paper
• Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients

  2020cited by this paper
• Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition

  2020cited by this paper
• The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

  2019cited by this paper
• Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study

  2019cited by this paper
• Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients

  2019cited by this paper
• The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants

  2019cited by this paper
• Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients

  2019cited by this paper
• Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model

  2019cited by this paper
• FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine

  2018cited by this paper
• Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan

  2018cited by this paper
• Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings

  2018cited by this paper
• Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer

  2017influential reference
• Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene

  2017cited by this paper
• Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability

  2017cited by this paper
• Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan

  2016cited by this paper
• Revisiting the value and role of anti-angiogenesis in solid tumors and the mechanism to inhibit angiogenesis, and their possible complications: Pediatric oncologists view

  2016cited by this paper
• High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients

  2016cited by this paper
• Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2‐negatively tested breast cancer patients

  2016cited by this paper
• Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.

  2015cited by this paper
• Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study

  2015cited by this paper
• Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

  2015cited by this paper
• FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

  2015cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan

  2015cited by this paper
• Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan

  2014cited by this paper
• Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

  2014influential reference
• Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan

  2013cited by this paper
• Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles

  2013cited by this paper
• Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients

  2012cited by this paper
• A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma

  2011cited by this paper
• Mutations in Fanconi anemia genes and the risk of esophageal cancer

  2011cited by this paper
• Mutation of the RAD51C gene in a Fanconi anemia–like disorder

  2010cited by this paper
• Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.

  2009cited by this paper
• Aberrant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization

  2007cited by this paper
• Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.

  2007cited by this paper
• Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players.

  2007cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

  2006cited by this paper
• Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

  2006cited by this paper
• The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia

  2005cited by this paper
• Current and emerging techniques for diagnostic mutation detection: an overview of methods for mutation detection.

  2004cited by this paper
• Biallelic Inactivation of BRCA2 in Fanconi Anemia

  2002cited by this paper
• Statistical features of human exons and their flanking regions.

  1998cited by this paper

• BREAST CANCER IN PAKISTAN-AN UPDATED OVERVIEW

  2022cites this paper